Max Higgins, Senior Consultant, Author at EverGlade

Max Higgins, Senior Consultant

Max Higgins, Senior Consultant
DARPA’s Virtual-Integrated Twin

DARPA’s Virtual-Integrated Twin for Autonomous Lifesaving

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-SN-26-50 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-50 announcing additional research areas of interest for the forthcoming Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) program. This Special Notice serves as public notification ahead of a formal solicitation that will be released on SAM.gov. DARPA’s overarching […]

DARPA’s Virtual-Integrated Twin for Autonomous Lifesaving Read More »

DARPA BORDEAUX Program

DARPA’s BORDEAUX Program to Advance Cyber Security Performance in Artificial Intelligence

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-20 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released Program Solicitation DARPA-PS-26-20 for the BORDEAUX program. DARPA, the Department of Defense’s (DoD) premier research and development agency, is charged with making pivotal early technology investments that create technological surprise for national security. With BORDEAUX, DARPA is soliciting innovative

DARPA’s BORDEAUX Program to Advance Cyber Security Performance in Artificial Intelligence Read More »

DOE Funding to Accelerate Next-Generation Geothermal Field Testing and Resource Confirmation

DOE Launches $171.5M Initiative to Accelerate Next-Generation Geothermal Field Testing and Resource Confirmation

Leave a Comment / DOE, Emerging Technologies / By

DOE-FOA-0003472 Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation Part 1 The U.S. Department of Energy (DOE) Office of Geothermal (OG) has released Notice of Funding Opportunity (NOFO) DE-FOA-0003472, titled Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation. This solicitation represents a significant federal investment in advancing geothermal energy technologies capable

DOE Launches $171.5M Initiative to Accelerate Next-Generation Geothermal Field Testing and Resource Confirmation Read More »

ARPA-H ADVOCATE Program

ARPA-H’s ADVOCATE Program: What Amendment 02 Means for Proposers

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ADVOCATEISO_ARPA-H-SOL-26-142_Amendment02 The Advanced Research Projects Agency for Health (ARPA-H) released Amendment 02 to its ADVOCATE solicitation (ARPA-H-SOL-26-142), refining technical expectations, evaluation criteria, and program execution details for one of its most ambitious artificial intelligence initiatives in healthcare. ADVOCATE is designed to accelerate the development, evaluation, and scalable deployment of clinical artificial intelligence (AI) agents that

ARPA-H’s ADVOCATE Program: What Amendment 02 Means for Proposers Read More »

ARPA-H CIRCLE Program

ARPA-H’s CIRCLE Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ISO+Amd+1+-+CIRCLE The Advanced Research Projects Agency for Health (ARPA-H), through its Resilient Systems Office (RSO), has released an Innovative Solutions Opening (ISO) titled Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE), ARPA-H-SOL-26-139 . This solicitation reflects ARPA-H’s mandate to pursue bold, high-impact biomedical innovations that can transform patient outcomes at scale. With CIRCLE,

ARPA-H’s CIRCLE Program Read More »

BARDA domestic manufacturing essential medicines

BARDA Advances Domestic Manufacturing Capacity for Essential Medicines

Leave a Comment / BARDA, Life Sciences / By

BARDA 26-2-AM-LVP-RPP-Amendment 1 The Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services (HHS), has released a new Request for Project Proposals (RPP) aimed at strengthening the nation’s domestic pharmaceutical manufacturing base. Issued through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP Consortium), RPP 26-2-AM-LVP focuses on the commercial scale

BARDA Advances Domestic Manufacturing Capacity for Essential Medicines Read More »

DTRAs Six Basic Research Topics

Deep Dive Into DTRA’s Six Basic Research Topics

Leave a Comment / DTRA, Life Sciences / By

HDTRA125S0001 Topics Release Final Amendment 4 The Defense Threat Reduction Agency (DTRA), through its Research and Development (RD) Directorate and Chemical and Biological Technologies Department, has released Amendment 4 to its Broad Agency Announcement (BAA) titled Fundamental Research to Counter Weapons of Mass Destruction (C-WMD). This long-term funding vehicle reflects DTRA’s sustained commitment to advancing

Deep Dive Into DTRA’s Six Basic Research Topics Read More »

SMART antiviral prize

The SMART Antiviral Prize: A $100 Million Opportunity to Advance Broad-Spectrum Antiviral Development

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has launched the Small Molecule Approaches for Rapid and Robust Treatment (SMART) Antiviral Prize. This opportunity, introduced in collaboration with BARDA Accelerator Network, VITAL,  is a $100

The SMART Antiviral Prize: A $100 Million Opportunity to Advance Broad-Spectrum Antiviral Development Read More »

ARPA-H BIOGAMI

ARPA-H Launches BIOGAMI to Transform Therapeutics for Protein Misfolding Diseases

Leave a Comment / ARPA-H, Life Sciences / By

BIOGAMI ISO ARPA-H-SOL-26-149 The Advanced Research Projects Agency for Health (ARPA-H) has released a new Innovative Solutions Opening (ISO) for the BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI) program. Announced under ARPA-H-SOL-26-149, BIOGAMI reflects ARPA-H’s mission to pursue high-risk, high-reward research that can fundamentally transform health outcomes. The program is focused on addressing

ARPA-H Launches BIOGAMI to Transform Therapeutics for Protein Misfolding Diseases Read More »

pSMILE Program RFP

Advancing Global Laboratory Quality Through NIAID’s pSMILE Program

Leave a Comment / Life Sciences, NIAID / By

pSMILE RFP_75N93025R00011 with Attachments The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has released a new Request for Proposals (RFP) for the Patient Safety Monitoring in International Laboratories (pSMILE) program. Issued by NIAID’s Office of Acquisitions, this solicitation seeks to strengthen the quality, reliability, and regulatory

Advancing Global Laboratory Quality Through NIAID’s pSMILE Program Read More »

DARPA’s PICASSO Program

DARPA’s PICASSO Program

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-13-Amendment-01 The Defense Advanced Research Projects Agency (DARPA), through its Microsystems Technology Office (MTO), has released a new program solicitation for Photonic Integrated Circuit Architectures for Scalable System Objectives (PICASSO). This solicitation reflects DARPA’s continued interest in unlocking transformational system-level performance gains by rethinking how emerging technologies are architected, rather than incrementally improved. With PICASSO,

DARPA’s PICASSO Program Read More »

ARPA-H ADVOCATE Program

ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI

Leave a Comment / ARPA-H, Life Sciences / By

ARPA-H-SOL-26-142_ADVOCATE+ISO ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI The Advanced Research Projects Agency for Health (ARPA-H) has released a new Innovative Solutions Opening (ISO), Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE), aimed at fundamentally modernizing how chronic cardiovascular disease (CVD) is managed in the United States. Announced by ARPA-H’s Scalable Solutions Office (SSO),

ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI Read More »

Scroll to Top